Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Cardeza Foundation for Hematologic Research | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This research project is studying the causes for low platelet levels in preterm infants. Platelets are a component of blood that helps with clotting. The purpose of this study is to determine whether the cause for low platelet levels is the same in infants who are born to mothers with preeclampsia and infants who are small for gestational age.
Thrombocytopenia is a common entity in infants who are born to mothers with preeclampsia and in infants who are small for gestational age. There have been several theories to the mechanism underlying thrombocytopenia in these groups of patients. One mechanism suggests that thrombocytopenia in these populations may be secondary to underproduction of platelets. Other studies have implied that low platelet levels may be due to endothelial activation causing platelet consumption. This study is being performed to help determine the mechanism causing thrombocytopenia in infants born to mothers with preeclampsia and comparing it to the mechanism of thrombocytopenia in infants who are small for gestational age.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SGA infants | Infants who are thought to be small for gestational age (SGA) |
| |
| Pre-eclampsia exposed | Infants who are born to mothers who had pre-eclampsia |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cord blood | Procedure | Cord blood will be obtained at the time of delivery. |
|
| Measure | Description | Time Frame |
|---|---|---|
| To determine the mechanism of thrombocytopenia in small for gestational age infants versus infants with maternal preeclampsia exposure | Each infant will only be enrolled during the time of birth until cord blood is collected. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
In utero infants who are small for gestational age or who are exposed to maternal pre-eclampsia
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kelly Zook, MD | Christiana Care Health Systems; Thomas Jefferson University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Christiana Care Health Systems | Newark | Delaware | 19713 | United States |
Not provided
| ID | Term |
|---|---|
| D013921 | Thrombocytopenia |
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D001791 | Blood Platelet Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D000095542 | Cytopenia |
Not provided
Not provided
Not provided
Not provided
Not provided
Cord blood
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |